Results 91 to 100 of about 1,445 (106)

HLA-DR1 is associated with vitiligo

Immunology Letters, 1991
G Füst, V Stenszky, N R Farid
exaly  

Reoxygenation in the SCCVII tumor after KU-2285 sensitization plus single or fractionated irradiation

International Journal of Radiation Oncology Biology Physics, 1994
Yuta Shibamoto, Rumi Murata, Natsuo Oya   +2 more
exaly  

A fluorinated 2-nitroimidazole, ku-2285, as a new hypoxic cell radiosensitizer

International Journal of Radiation Oncology Biology Physics, 1991
Keisuke Sasai, Sei-Ichi Nishimoto, Yuta Shibamoto   +2 more
exaly  

HLA‐DR1 and rheumatoid arthntis in Israeli Jews: Sequencing reveals that DRB1*0102 is the predominant HLA‐DR1 subtype

Tissue Antigens, 1993
Marcel G J Tilanus, E Thorsby, Niek De Vries   +2 more
exaly  

Effect of TYB-2285 on antigen-induced accumulation of eosinophils into the peritoneal cavity of rats sensitized with Ascaris suum extract

General Pharmacology, 1997
Akihide Koda, Hideyo Shimada
exaly  

Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice

International Journal of Radiation Oncology Biology Physics, 1994
Keisuke Sasai, Yuta Shibamoto, Mitsuyuki Abe   +2 more
exaly  

All-trans- and 9-cis-retinoic acids activate the human cyclooxynase-2 gene: a role for DR1 as RARE or RXRE

Molecular Biology Reports, 2010
Irène Moon, Hyunjung Jade Lim
exaly  

The effects of TYB-2285 and its metabolites on eosinophil adhesion to tumor necrosis factor α-stimulated human umbilical vein endothelial cells

Allergology International, 1996
Akihide Koda
exaly  

KIN-804 vs. KU-2285 as a radiosensitizer for clinical use

International Journal of Radiation Oncology Biology Physics, 1994
Natsuo Oya, Yuta Shibamoto, Toru Shibata   +2 more
exaly  

The effects of TYB-2285 and its metabolites on lymphocyte responses In vitro

General Pharmacology, 1997
Akihide Koda, Hideyo Shimada
exaly